Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia

Heart rate reduction and longevity in mice

(2015) Sabine Gent et al.   BASIC RESEARCH IN CARDIOLOGY

Pleiotropic, heart rate-independent cardioprotection by ivabradine

(2015) P Kleinbongard et al.   BRITISH JOURNAL OF PHARMACOLOGY

Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging

(2015) Jens-Uwe Voigt et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?

(2014) P Kleinbongard et al.   BRITISH JOURNAL OF PHARMACOLOGY

Exercise Standards for Testing and Training

(2013) Gerald F. Fletcher et al.   CIRCULATION

The Regional Myocardial Flow–Function Relationship

(2013) Gerd Heusch   CIRCULATION RESEARCH

Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress

(2011) Swenja Kröller-Schön et al.   BASIC RESEARCH IN CARDIOLOGY

Cardioprotection by Ivabradine Through Heart Rate Reduction and Beyond

(2011) Gerd Heusch et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

(2008) G Heusch   BRITISH JOURNAL OF PHARMACOLOGY

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction

(2008) G. Heusch et al.   EUROPEAN HEART JOURNAL

Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)

(2008) R. Sicari et al.   European Journal of Echocardiography

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET